NEW YORK, Aug. 16, 2017 /PRNewswire/ -- Summary
GlobalData's new report, "Mexico Needle Free Injections Market Outlook to 2023", provides key market data on the Mexico Needle Free Injections market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) for Needle Free Injections.
The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
- Market size and company share data for Needle Free Injections.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
- 2016 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the Mexico Needle Free Injections market.
- Key players covered include INJEX - Equidyne Systems, Bioject Medical Technologies Inc and Antares Pharma Inc.
Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Read the full report: http://www.reportlinker.com/p05026531/Mexico-Needle-Free-Injections-Market-Outlook-to.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: [email protected]
Intl: +1 339-368-6001